Physical Activity and the Risk of COVID-19 Infection and Mortality

Sponsor
Wonju Severance Christian Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04631861
Collaborator
(none)
132,069
78.9

Study Details

Study Description

Brief Summary

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there is no cure for COVID-19, except for supportive treatments. Quarantine for a defined period is the best option to reduce the spread of COVID-19. Physical activity has been shown to reduce the risk of serious community-acquired infections. However, it remains unanswered is whether physical activity has protective effects against SARS-CoV-2 infection and COVID-19 related mortality. This study aimed to examine the association of PA with the morbidity and mortality of COVID-19 infection in the entire South Korean population.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    132069 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Physical Activity and the Risk of COVID-19 Infection and Mortality
    Actual Study Start Date :
    Jan 1, 2014
    Actual Primary Completion Date :
    Jul 31, 2020
    Actual Study Completion Date :
    Jul 31, 2020

    Outcome Measures

    Primary Outcome Measures

    1. SARS-CoV-2 positivity rate (%) [7 years]

      The SARS-CoV-2 infection was confirmed using the real-time reverse transcriptase polymerase chain reaction of pharyngeal and nasal swab samples, in accordance with the WHO recommendations

    2. COVID-19 related mortality rate (%) [7 years]

      The COVID-19 related mortality was defined as the termination of isolation due to death.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • all Koreans who tested positive for SARS-CoV-2

    • more than 18 years old

    • who underwent public health screening between 2014 and 2017

    Exclusion Criteria:
    • missing values about physical activity

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Wonju Severance Christian Hospital

    Investigators

    • Principal Investigator: Dong-Hyuk Cho, Yonsei Wonju Christian Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dong-Hyuk Cho, Clinical assistant professor, Wonju Severance Christian Hospital
    ClinicalTrials.gov Identifier:
    NCT04631861
    Other Study ID Numbers:
    • 2020AN0292
    First Posted:
    Nov 17, 2020
    Last Update Posted:
    Nov 17, 2020
    Last Verified:
    Nov 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dong-Hyuk Cho, Clinical assistant professor, Wonju Severance Christian Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 17, 2020